Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02259049 · ClinicalTrials.gov registry record · Early Phase 1
The Effects of L-Tyrosine on 24 Hour Blood Pressure and Heart Rate in Parkinson's Disease
A Early Phase 1 study of Blood Pressure, sponsored by New York Institute of Technology.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT02259049 is a Early Phase 1 study of Blood Pressure that has completed, run by New York Institute of Technology. The registered enrollment target is 6 participants, below the 287-participant average among 101 other Blood Pressure trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02259049, a Early Phase 1 study of Blood Pressure, has completed, sponsored by New York Institute of Technology.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are observing the effects 2,000 mg of L-tyrosine will have on 24 hour blood pressure fluctuations in individuals with Parkinson's disease.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Sugar Pill
- DIETARY_SUPPLEMENT L-tyrosine
Study Locations (1)
New York
- New York Institute of Technology - Old Westbury
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2014-10 |
| Est. Completion | 2015-09 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02259049
The ClinicalTrials.gov registry entry for NCT02259049 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 287-participant average among 101 other Blood Pressure trials with a reported enrollment target (98% lower). The listed sponsor is New York Institute of Technology, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Blood Pressure appearing as the primary indexed condition, and to 2 interventions - of which Sugar Pill is the first listed.
NCT02259049 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02259049 about?
NCT02259049 is a clinical study titled "The Effects of L-Tyrosine on 24 Hour Blood Pressure and Heart Rate in Parkinson's Disease". The investigators are observing the effects 2,000 mg of L-tyrosine will have on 24 hour blood pressure fluctuations in individuals with Parkinson's disease.
What is the current status of trial NCT02259049?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 6 participants. The study started on 2014-10. Estimated completion is 2015-09.
What conditions does trial NCT02259049 study?
This clinical trial studies the following conditions: Blood Pressure.
What interventions are being tested in trial NCT02259049?
The interventions under investigation include: Sugar Pill (DIETARY_SUPPLEMENT), L-tyrosine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02259049?
This trial is sponsored by New York Institute of Technology, which has 49 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02259049 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Pressure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Autonomic Control of the Circulation and VDR
RECRUITING · Early Phase 1
-
Reversing Glucose and Lipid-mediated Vascular Dysfunction
RECRUITING · Early Phase 1
-
Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia
RECRUITING · Early Phase 1
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
RECRUITING
-
Autonomic Regulation of Blood Pressure in Premature and Early Menopausal Women
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.